Virtual reality pathfinding errors may flag early Alzheimer's risk before symptoms appear

· Medical Xpress

by Fujita Health University

edited by Sadie Harley, reviewed by Robert Egan

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Associate Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

Researchers assess navigation performance using a head-mounted immersive 3D VR device and demonstrate that VR path integration performance may help predict risk of neurodegenerative diseases, including Alzheimer's disease, potentially facilitating timely lifestyle modifications and therapeutic interventions. Credit: Dr. Hirohisa Watanabe from Fujita Health University, Japan link.springer.com/article/10.1186/s13195-026-02056-x

Alzheimer's disease (AD) often begins long before it is clinically recognized, with subtle brain changes emerging years before noticeable memory loss or cognitive decline. Among the earliest regions affected are the hippocampus and entorhinal cortex, areas essential for spatial navigation. This has led researchers to look beyond memory and explore navigation ability as a potential early indicator of the disease.

One key component of navigation is path integration (PI), the brain's ability to track position and direction using internal cues such as movement and balance. As these systems begin to deteriorate, disruptions in PI may appear early, making it a promising behavioral marker of preclinical AD. Despite growing interest in this idea, a key question is whether PI deficits can predict structural brain changes.

To address this, a team of researchers led by Senior Assistant Professor Kazuya Kawabata, Dr. Sayuri Shima, and Prof. Hirohisa Watanabe from the Department of Neurology, Fujita Health University, Japan, conducted a study to examine whether subtle impairments in virtual-reality PI (VR-PI) could signal future neurodegeneration in cognitively healthy individuals.

Their findings are published in the journal Alzheimer's Research & Therapy.

Researchers reveal that baseline virtual-reality PI performance is associated with accelerated cortical thinning in vulnerable brain regions and is tied to key blood biomarkers such as p-tau181 and glial fibrillary acidic protein levels of neurodegeneration. Credit: Dr. Hirohisa Watanabe, Fujita Health University, Japan

How the virtual navigation test worked

The study followed 71 cognitively unimpaired adults over approximately one year. At baseline, participants completed an immersive VR navigation task designed to assess PI ability. In this task, individuals navigated a circular virtual environment, visited two checkpoints, and were then asked to return to their starting point without visual cues. Two primary measures were derived: PI error (distance from the true starting point) and angular error (directional deviation).

In addition, high-resolution magnetic resonance imaging (MRI) scans were analyzed to assess structural changes such as longitudinal cortical thickness and volume.

Moreover, Alzheimer's-related plasma biomarkers, including p-tau181 and glial fibrillary acidic protein (GFAP), were assessed. Longitudinal brain changes were analyzed using linear mixed-effects models to evaluate whether baseline PI performance predicted structural decline.

Brain changes tied to navigation errors

The results revealed a clear pattern. Individuals with higher PI error at baseline showed greater cortical thinning and volume loss over the follow-up period. These changes were observed in brain regions known to be vulnerable in early AD, including the parahippocampal gyrus, middle temporal gyrus, posterior cingulate cortex, and caudal middle frontal gyrus.

Notably, angular error showed similar patterns of association while exhibiting weaker age-related effects, supporting the robustness of navigation-based measures.

Importantly, these behavioral findings were closely tied to biological processes. Higher PI and angular errors were associated with increased levels of plasma p-tau181, while PI error was also linked to GFAP levels.

This indicates that navigation deficits are not merely performance differences but reflect underlying neurodegenerative changes. In fact, PI error was able to identify individuals with the most rapid brain decline, particularly in the parahippocampal region, with high accuracy.

"Our findings suggest that VR-PI performance captures both molecular (blood biomarker) and structural (MRI) signatures that emerge before overt clinical impairment," says Dr. Kawabata.

This dual link strengthens its potential as an early and sensitive marker of neurodegenerative vulnerability.

Implications for early Alzheimer's detection

Overall, this study demonstrates that impaired PI is closely associated with subsequent brain degeneration and Alzheimer's-related biomarkers, even among cognitively healthy individuals. By bridging behavior, brain structure, and molecular signals, it highlights VR-PI performance as a promising early indicator of AD and a potential tool for its early detection and monitoring.

"Our approach may allow earlier identification of the risk of neurodegenerative diseases, including AD. Over the longer term, it may contribute to a shift toward earlier detection, potentially enabling timely therapeutic interventions at preclinical stages and delaying disease progression, thereby preserving cognitive function and quality of life," concludes Dr. Kawabata.

Publication details

Kazuya Kawabata et al, VR-based path integration predicts individual risk of rapid cortical decline: a one-year longitudinal study in cognitively unimpaired adults, Alzheimer's Research & Therapy (2026). DOI: 10.1186/s13195-026-02056-x

Journal information: Alzheimer's Research & Therapy

Key medical concepts

Alzheimer's DiseaseTau protein.phosphorylated 181Glial Fibrillary Acidic Protein

Clinical categories

NeurologyCommon illnesses & PreventionHealthy aging Provided by Fujita Health University Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Virtual reality pathfinding errors may flag early Alzheimer's risk before symptoms appear (2026, May 27) retrieved 28 May 2026 from https://medicalxpress.com/news/2026-05-virtual-reality-pathfinding-errors-flag.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.